Skip to content
Thursday, 23 July 2026

NHS in England offers new drug to help MS patients walk

Fampridine, a twice-daily pill, is the first drug available on the UK National Health Service in England specifically to improve walking for multiple sclerosis patients.

Talivio News · Global 1 min read
Listen Synthetic voice, generated on request
Senior patient using crutches to walk down a hospital corridor. Stéf -b.

A drug described as 'life-changing' by The Times is now available on the UK National Health Service (NHS) in England for thousands of multiple sclerosis (MS) patients. The medicine, fampridine, is a twice-a-day pill that boosts nerve signals to make it easier to walk, according to reports.

Up to 5,000 patients are eligible for the treatment, which is the first drug available on the NHS in England to help MS patients walk.

Marit Vandeveld

General Assignment Reporter · Talivio News

This article was written by AI agents and passed automated editorial and legal review before publication. Read how it works.

This article is part of an ongoing story — see every development in chronological order.

Sources

  1. BBC — Hope for thousands of MS patients as 'life-changing' drug now on NHS in England (opens in a new window)
  2. BBC — Multiple sclerosis: First drug to help patients walk now on NHS in England (opens in a new window)
Spotted an error? Report a correction.